Overview
Patients with achondroplasia face unique challenges when undergoing bariatric surgery. The recent case report on peri‑operative anesthetic management for bariatric surgery in a 29‑year‑old woman with achondroplasia and morbid obesity (BMI 69 kg/m²) who had previously undergone 17 cm of lower‑limb lengthening highlights how body proportions—not just standing height—drive airway and positioning decisions. This guide distills the findings, translates them into plain language, and provides practical take‑aways for patients and families considering similar procedures.
What This Study Examined
The authors described a single‑patient, retrospective case report that focused on the anesthesia plan for a morbidly obese individual with achondroplasia who previously received distraction osteogenesis. Specific interventions included high‑flow nasal oxygen, a hyper‑angulated videolaryngoscope (X‑blade), quantitative neuromuscular monitoring, and reversal with sugammadex.
Why This Matters for Patients
For patients with achondroplasia, standard airway‑management techniques (ramp positioning, conventional laryngoscope blades) may be inadequate, even after limb lengthening increases overall height. Understanding the nuanced peri‑operative strategies can reduce the risk of airway loss, hypoxemia, and postoperative complications during bariatric surgery—a life‑changing operation for those with severe obesity.
Medical Background
Achondroplasia is the most common form of dwarfism, caused by a mutation in the FGFR3 gene. Hallmark features include a short stature with a relatively normal trunk, macrocephaly, and a narrowed upper airway. When morbid obesity coexists, the risk of difficult airway and respiratory compromise rises sharply.
Bariatric surgery, such as sleeve gastrectomy or Roux‑en‑Y gastric bypass, is an effective treatment for severe obesity (BMI ≥ 40 kg/m² or ≥ 35 kg/m² with comorbidities). The procedure reduces gastric volume, leading to sustained weight loss and improvement in obesity‑related conditions.
How the Procedure Works
During a sleeve gastrectomy, the surgeon removes a large portion of the stomach using laparoscopic stapling, creating a narrow gastric tube. This limits food intake and promotes early satiety. In a gastric bypass, a small stomach pouch is created and attached directly to the small intestine, bypassing a portion of the duodenum and jejunum.
Who Is a Candidate?
Typical candidates are adults with a BMI ≥ 40 kg/m² or a BMI ≥ 35 kg/m² with serious health problems (e.g., type 2 diabetes, sleep apnea). Patients with achondroplasia are eligible if they meet these criteria and are otherwise cleared for surgery after a thorough multidisciplinary evaluation.
Clinical Summary
- Procedure: Bariatric surgery (laparoscopic sleeve gastrectomy)
- Typical Duration: 90–120 minutes for sleeve gastrectomy; up to 180 minutes for gastric bypass
- Recovery: Hospital stay 1–3 days; return to light activity in 2–4 weeks
- Success Rate (general): 50–70 % excess weight loss at 2 years, with improvement in obesity‑related comorbidities in >80 % of patients
Study Methodology
This publication is a case report, not a randomized trial. The authors retrospectively reviewed the peri‑operative record of a single 29‑year‑old woman with genetically confirmed achondroplasia and a body mass index of 69 kg/m². The patient had previously undergone bilateral lower‑limb distraction osteogenesis, resulting in a 17‑cm increase in standing height (from 121 cm to 138 cm). Despite the height gain, the torso length remained characteristic of achondroplasia, preserving the typical cranio‑cervical and thoracic proportions.
Pre‑operative assessment included a detailed airway examination (Mallampati III, limited neck extension, high‑arched palate), pulmonary function testing (forced vital capacity 45 % predicted), and cardiac evaluation (echocardiogram showing mild left‑ventricular hypertrophy). The anesthesia team performed a simulated “ramp” positioning trial on the operating table, noting that standard ramped positioning produced excessive lumbar flexion and failed to align the oral, pharyngeal, and laryngeal axes.
Anesthetic plan was formulated with the following goals:
- Maintain oxygenation during potentially prolonged airway manipulation using high‑flow nasal oxygen (HFNO) at 50 L/min with FiO₂ 1.0.
- Utilize quantitative neuromuscular monitoring (train‑of‑four) to avoid residual paralysis.
- Employ a hyper‑angulated videolaryngoscope (X‑blade, 64° curvature) after an unsuccessful attempt with a conventional videolaryngoscope blade.
- Facilitate rapid reversal with sugammadex (2 mg/kg) to enable a safe and awake extubation.
The case was managed in a tertiary academic center equipped with a dedicated bariatric operating suite, a video‑recorded airway cart, and an experienced anesthesia team including a senior anesthesiologist, a resident, and a certified registered nurse anesthetist.
Results & Findings
During induction, the patient received pre‑oxygenation with HFNO for 5 minutes, achieving an SpO₂ of 100 %. After rapid‑sequence induction with propofol (2 mg/kg) and fentanyl (2 µg/kg), neuromuscular blockade was achieved with rocuronium 0.6 mg/kg. The first laryngoscopic attempt using a standard Macintosh‑style videolaryngoscope blade yielded a Cormack‑Lehane grade III view, and intubation failed after three attempts. The total duration of the failed attempts was 2 minutes 30 seconds, during which SpO₂ dipped to a nadir of 92 % despite ongoing HFNO.
Promptly switching to the hyper‑angulated X‑blade produced a clear grade IIb view, and the endotracheal tube (size 6.0 mm internal diameter) was placed on the first pass. Time from blade insertion to successful intubation was 45 seconds, and SpO₂ returned to 99 % within 30 seconds of tube placement.
Quantitative neuromuscular monitoring showed a train‑of‑four ratio of 0.2 at the end of the 90‑minute surgical procedure. Sugammadex 150 mg (2 mg/kg) was administered, and the ratio recovered to 0.9 within 2 minutes, allowing for an awake extubation with the patient responding to verbal commands.
Post‑operatively, the patient required supplemental oxygen via nasal cannula (2 L/min) for 6 hours, after which she maintained SpO₂ > 95 % on room air. No airway complications, aspiration events, or unexpected hemodynamic instability were reported. She was discharged home on postoperative day 2 with clear instructions for pain control and respiratory exercises.
Key quantitative findings from the case include:
- Failed intubation attempts with standard blade: 3 attempts, 2.5 minutes total.
- Successful intubation with hyper‑angulated blade: 1 attempt, 45 seconds.
- Lowest intra‑operative SpO₂: 92 % (brief desaturation).
- Sugammadex dose: 150 mg (2 mg/kg); reversal time: 2 minutes.
- Length of surgery: 115 minutes; anesthesia time: 130 minutes.
These data support the hypothesis that body proportions, rather than absolute height, dictate airway difficulty in achondroplasia patients, even after substantial limb lengthening.
Clinical Implications
The case underscores several practical lessons for anesthesiologists, bariatric surgeons, and peri‑operative teams caring for patients with achondroplasia and severe obesity:
- Body proportion assessment supersedes standing height. The short trunk and disproportionate neck–head ratio remain unchanged after distal limb lengthening. Pre‑operative airway assessment should therefore focus on cervical spine mobility, Mallampati class, and mandibular size rather than relying on height alone.
- High‑flow nasal oxygen is a valuable adjunct. HFNO provided a safety net during the 2‑minute desaturation period, allowing the patient to recover quickly after successful intubation.
- Hyper‑angulated videolaryngoscopy should be available as first‑line equipment. The X‑blade’s 64° curvature accommodates the anteriorly positioned glottic opening typical of achondroplasia, reducing the number of attempts and limiting hypoxemia.
- Quantitative neuromuscular monitoring and sugammadex improve extubation safety. Real‑time train‑of‑four ratios enable tailored dosing of reversal agents, preventing residual blockade that could precipitate postoperative airway obstruction.
- Positioning modifications are essential. In this patient, a customized “partial‑ramp” (45° torso elevation with pillow support under the shoulders) aligned the airway axes without excessive lumbar flexion, illustrating the need for individualized positioning strategies.
From the patient’s perspective, these strategies translate into a lower risk of peri‑operative complications, a smoother recovery, and greater confidence that their unique anatomy will be respected throughout the surgical journey.
Future research should aim to collect a series of achondroplasia patients undergoing bariatric procedures to validate these findings, compare outcomes between conventional and hyper‑angulated videolaryngoscopes, and quantify the cost‑effectiveness of routine HFNO use.
Frequently Asked Questions
- Q: Does limb‑lengthening surgery make airway management easier for someone with achondroplasia?
- A: No. While limb lengthening increases overall standing height, it does not change the short trunk and narrowed upper airway that characterize achondroplasia. Airway difficulty is still determined by the proportion of torso to neck, not by the total height.
- Q: What is high‑flow nasal oxygen and why is it used?
- HFNO delivers heated, humidified oxygen at flow rates up to 60 L/min, providing both apneic oxygenation and a modest positive airway pressure. It helps maintain oxygen saturation during intubation attempts, especially in obese patients who desaturate quickly.
- Q: Are hyper‑angulated videolaryngoscopes safe for all patients?
- They are safe when used by clinicians familiar with their optics. In patients with a forward‑projecting larynx—common in achondroplasia—these blades often improve glottic visualization compared with standard blades.
- Q: Why was sugammadex chosen instead of neostigmine for reversal?
- Sugammadex directly encapsulates rocuronium molecules, providing rapid and complete reversal even when deep blockade is present. This reduces the risk of residual paralysis and associated airway obstruction after extubation.
- Q: How long will I stay in the hospital after bariatric surgery if I have achondroplasia?
- Most patients are discharged after 1–3 days, provided there are no complications. The presence of achondroplasia does not inherently prolong stay, but close monitoring of airway and respiratory function is recommended.
Conclusion
This case report highlights that anesthetic planning for bariatric surgery in patients with achondroplasia must prioritize anatomical proportions over absolute height. The combination of high‑flow nasal oxygen, hyper‑angulated videolaryngoscopy, quantitative neuromuscular monitoring, and sugammadex reversal proved effective and safe in a morbidly obese patient with prior limb‑lengthening. By adopting these evidence‑based strategies, clinicians can mitigate airway risk, improve peri‑operative outcomes, and empower patients with achondroplasia to pursue life‑changing bariatric procedures with confidence.